The European Commission has already said that Hungary’s plans to import and possibly use Russia’s Sputnik V vaccine raise safety concerns and could damage trust in vaccines.

Neither Russia nor China has yet sought EMA approval for any of the vaccines it is developing.

Szijjarto did not say which Chinese vaccine Hungary was seeking to fast-track. On Thursday, he told parliament Hungary was working with three Chinese manufacturers, of which two are private firms and one state-owned, but did not name any of them.

China has approved three vaccine candidates developed by Sinovac Biotech Ltd and state-owned China National Pharmaceutical Group (Sinopharm) for emergency use in China, and Sinopharm hopes its two candidates will get conditional approval for general use this year.

Budapest has become used to deviating from a collective EU approach. Prime Minister Viktor Orban delayed the bloc’s 1.85 trillion euro ($2.24 trillion) budget and recovery package by several weeks because of objections to rule-of-law conditions. Source: Hungary plans fast-track local approval for Chinese COVID vaccine – The Jerusalem Post